Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension

  • STATUS
    Recruiting
  • End date
    Feb 20, 2023
  • participants needed
    90
  • sponsor
    Henan Institute of Cardiovascular Epidemiology
Updated on 6 September 2021
hypertension
calcium
systolic blood pressure
beta blockers
antihypertensive drugs
blood pressure diastolic

Summary

According to the latest survey data of China hypertension annual meeting, there are about 300 million patients with hypertension in China, with 10 million new cases of hypertension each year, and there is an obvious trend of younger people. In particular, young and middle-aged people are in a state of mild hypertension for a long time, which causes great pressure on health and medical treatment. At present, the main clinical measures for mild hypertension are to change their eating habits, quit smoking and alcohol, exercise and other lifestyle changes, as well as drug control. For most patients with mild hypertension, drug control is not the best choice. It has been reported that remote ischemic preconditioning (RIPC) may play an effective role in reducing blood pressure .The purpose of this study was to investigate the extent of long-term application of RIPC to reduce blood pressure in patients with mild hypertension.

Description

A total of 200 patients with mild hypertension were enrolled in this study, using the method of open label and parallel grouping; 100 cases in the experimental group and 100 cases in the control group, The experimental group was divided into life intervention + drug group and life intervention + ripc group, with 50 patients in each group. The results of 24-hour ambulatory blood pressure monitoring (ABPM) of the three groups were observed before and 3 months after use, including HR, pulse pressure, 24-hour systolic blood pressure, 24-hour diastolic blood pressure, daytime systolic blood pressure, daytime diastolic blood pressure, nighttime systolic blood pressure and nighttime diastolic blood pressure. The changes of renalase, catecholamine, renin, angiotensin - , aldosterone, RhoA kinase, no, adenosine and bradykinin were observed.

Details
Condition Hypertension, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric), Vascular Diseases, Diabetes and Hypertension, high blood pressure, Elevated Blood Pressure, arterial hypertension
Treatment Lifestyle intervention, remote ischemic preconditioning(RIPC), Antihypertensive drugs, Antihypertensive drugs
Clinical Study IdentifierNCT04753840
SponsorHenan Institute of Cardiovascular Epidemiology
Last Modified on6 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosed patients with mild hypertension (SBP: 140~159mmHg; DBP: 90~99mmHg)

Exclusion Criteria

Cannot tolerate RIPC
Non-essential hypertension
patients who have uncontrolled severe arrhythmia, diabetes, electrolyte disturbance
patients who have severe organic diseases such acute myocardial infarction, cardiac insufficiency, abnormal renal function, etc
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note